Myriad Genetics paid its 8 named executives $23.5M in total in FY2025 (Dec). CEO Samraat S. Raha was paid $5.7M of that.
Pay$100 in the stock at the end of FY23 → $32
Pay of each named executive
Brian J. DonnellyChief Commercial Officer
| FY2025 (Dec) |
1 year
Samraat S. RahaPresident and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed |
2 years
Mark S. VerrattiChief Operating Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Scott J. LefflerFormer Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed |
2 years
Margaret AnconaFormer EVP, Strategy and Transformation
| FY2025 (Dec) |
1 year
Dale Muzzey, Ph.D.Chief Scientific Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
Benjamin R. WheelerChief Financial Officer
| FY2025 (Dec) |
1 year
Paul J. DiazFormer President and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.